Figure 6.
Transgene expression by human CD34+ cells that were cultured in vitro for 14 days after immunobead selection from the chimeric mouse bone marrow. Immunobead-selected and cultured nontransduced X-CGD CD34+ cells served as negative control for gp91phox (A) and CFP (D) expression, respectively. (B-C) Shown are representative analyses of gp91phox expression of transduced MFGS-gp91phox X-CGD CD34+ PBSCs and MFGS-CFP–transduced normal CD34+ PBSCs, respectively, in which gp91phox transgene expression was detected in 10% of cells, and native gp91phox expression was detected in 76% of cells. (E) Shown is a representative analysis of CFP transgene expression by MFGS-CFP–transduced normal CD34+ PBSCs in culture, in which CFP expression was detected in 24% of cells.